Astro-Med, Inc.: Astro-Med's Grass Technologies Awarded Contract for Sleep and Neurology Products by Broadlane Inc.
WEST WARWICK, RI--(Marketwire - January 26, 2009) - Astro-Med, Inc. (
"It is gratifying to have won this valuable contract, after having been in intensive negotiations with Broadlane, and being selected over other manufacturers of similar products," said Marco Mancini, Sales Manager of Grass Technologies. Mancini continued, "Now, member hospitals of the Broadlane organization will be prompted to purchase Grass Technologies products based on three key benefits: the performance advantages of our technology, our technical support excellence, and our competitive pricing."
In May 2008, Grass Technologies announced a two-year contract with Premier, a Group Purchasing Organization (GPO), for purchasing of Grass® sleep diagnostic systems.
Grass Technologies, an Astro-Med, Inc. Product Group, has designed, manufactured, and sold PSG, EEG, and other neurophysiological monitoring systems for use by hospitals and labs around the world since 1935. Grass recently announced the introduction of SleepTrek3, a sleep diagnostic system for home use, and the Neurotrac III Neuromonitoring system for monitoring EEG in patients in the ICU and OR.
About Astro-Med, Inc.
Astro-Med, Inc. (
About Broadlane Inc.
Broadlane is the leading technology-oriented healthcare services company, reducing cost and creating operational efficiencies for thousands of acute care hospitals, ambulatory care facilities, physician practices and other healthcare providers in the United States. Its core services include supply chain management and clinical workforce management services. Broadlane is a private company with headquarters in Dallas, TX. More information is available at [ www.broadlane.com ].
Safe Harbor Statement
This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2008 annual report and its annual and quarterly filings with the Securities and Exchange Commission.